Literature DB >> 18996376

Identification of the P-TEFb complex-interacting domain of Brd4 as an inhibitor of HIV-1 replication by functional cDNA library screening in MT-4 cells.

Emiko Urano1, Yumi Kariya, Yuko Futahashi, Reiko Ichikawa, Makiko Hamatake, Hidesuke Fukazawa, Yuko Morikawa, Takeshi Yoshida, Yoshio Koyanagi, Naoki Yamamoto, Jun Komano.   

Abstract

We conducted a phenotypic cDNA screening using a T cell line-based assay to identify human genes that render cells resistant to human immunodeficiency virus type 1 (HIV-1). We isolated potential HIV-1 resistance genes, including the carboxy terminal domain (CTD) of bromodomain-containing protein 4 (Brd4). Expression of GFP-Brd4-CTD was tolerated in MT-4 and Jurkat cells in which HIV-1 replication was markedly inhibited. We provide direct experimental data demonstrating that Brd4-CTD serves as a specific inhibitor of HIV-1 replication in T cells. Our method is a powerful tool for the identification of host factors that regulate HIV-1 replication in T cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18996376     DOI: 10.1016/j.febslet.2008.10.047

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  7 in total

1.  A carboxy-terminally truncated human CPSF6 lacking residues encoded by exon 6 inhibits HIV-1 cDNA synthesis and promotes capsid disassembly.

Authors:  Takanori Hori; Hiroaki Takeuchi; Hideki Saito; Ryuta Sakuma; Yoshio Inagaki; Shoji Yamaoka
Journal:  J Virol       Date:  2013-05-08       Impact factor: 5.103

2.  AF4 and AF4N protein complexes: recruitment of P-TEFb kinase, their interactome and potential functions.

Authors:  Bastian Scholz; Eric Kowarz; Tanja Rössler; Khalil Ahmad; Dieter Steinhilber; Rolf Marschalek
Journal:  Am J Blood Res       Date:  2015-06-15

3.  DDX6 transfers P-TEFb kinase to the AF4/AF4N (AFF1) super elongation complex.

Authors:  Fabian Mück; Silvia Bracharz; Rolf Marschalek
Journal:  Am J Blood Res       Date:  2016-09-15

4.  Two-pronged binding with bromodomain-containing protein 4 liberates positive transcription elongation factor b from inactive ribonucleoprotein complexes.

Authors:  Sebastian Schröder; Sungyoo Cho; Lei Zeng; Qiang Zhang; Katrin Kaehlcke; Lily Mak; Joann Lau; Dwayne Bisgrove; Martina Schnölzer; Eric Verdin; Ming-Ming Zhou; Melanie Ott
Journal:  J Biol Chem       Date:  2011-11-14       Impact factor: 5.157

Review 5.  Twist-BRD4 complex: potential drug target for basal-like breast cancer.

Authors:  Jian Shi; Jingying Cao; Binhua P Zhou
Journal:  Curr Pharm Des       Date:  2015       Impact factor: 3.116

6.  Reactivation of latent HIV-1 by inhibition of BRD4.

Authors:  Jian Zhu; Gaurav D Gaiha; Sinu P John; Thomas Pertel; Christopher R Chin; Geng Gao; Hongjing Qu; Bruce D Walker; Stephen J Elledge; Abraham L Brass
Journal:  Cell Rep       Date:  2012-10-04       Impact factor: 9.423

7.  The mechanism of release of P-TEFb and HEXIM1 from the 7SK snRNP by viral and cellular activators includes a conformational change in 7SK.

Authors:  Brian J Krueger; Katayoun Varzavand; Jeffrey J Cooper; David H Price
Journal:  PLoS One       Date:  2010-08-23       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.